Literature DB >> 5801348

Low serum pseudocholinesterase levels complicating treatment with phenelzine.

P O Bodley, K Halwax, L Potts.   

Abstract

Four patients undergoing treatment with phenelzine developed low serum pseudocholinesterase levels. In one of the patients an apnoea of one hour followed modified electric convulsion therapy. In three cases investigations showed that the serum pseudocholinesterase levels returned to normal after withdrawal of phenelzine.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5801348      PMCID： PMC1984271          DOI： 10.1136/bmj.3.5669.510

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  5 in total

1.  REACTIONS DUE TO THE COMBINATION OF MONOAMINEOXIDASE INHIBITORS WITH THYMOLEPTICS, PETHIDINE, OR METHYLAMPHETAMINE.

Authors:  M NYMARK; I M NIELSEN
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

2.  An improved method for the estimation of cholinesterase activity in serum.

Authors:  F RAPPAPORT; J FISCHL; N PINTO
Journal:  Clin Chim Acta       Date:  1959-03       Impact factor: 3.786

3.  Dangerous potentiation of pethidine by iproniazid, and its treatment.

Authors:  J C SHEE
Journal:  Br Med J       Date:  1960-08-13

4.  Serum pseudocholinesterase in eczema.

Authors:  M D Trotter; E A Fairburn
Journal:  Br J Dermatol       Date:  1966 Aug-Sep       Impact factor: 9.302

5.  Serum albumin, pseudocholine-sterase, and transaminases in the assessment of liver function before and after venous shunt operations.

Authors:  A H HUNT; H LEHMANN
Journal:  Gut       Date:  1960-12       Impact factor: 23.059
  5 in total
  8 in total

Review 1.  MAOIs to RIMAs in anaesthesia--a literature review.

Authors:  S Hill; K Yau; J Whitwam
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

Review 3.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 4.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

5.  Electroconvulsive therapy: physiological and anaesthetic considerations.

Authors:  R J Marks
Journal:  Can Anaesth Soc J       Date:  1984-09

6.  Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.

Authors:  Ruslan Abdullayev; Ömer Burak Küçükebe; Recai Kaya; Bülent Çelik; Hatice Kuşderci; Mehmet Duran; Öznur Uludağ; Mesut Öterkuş; Aysel Buyrukcan; Ülkü Sabuncu; Abdullah Arpacı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01

Review 7.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

8.  Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.

Authors:  Brian C Geyer; Katherine E Larrimore; Jacquelyn Kilbourne; Latha Kannan; Tsafrir S Mor
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.